Kirkland Advises CD&R on Potential Partnership With Sanofi to Acquire Opella
October 22, 2024
October 22, 2024
CHICAGO, Illinois, Oct. 22 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis is advising CD&R on the M&A and reinvestment aspects as it enters into exclusive negotiations with Sanofi to acquire a 50% controlling stake in consumer healthcare champion, Opella, with Sanofi remaining a significant shareholder.
CD&R's acquisition of a controlling stake values Opella at approximately Euros16 billion (EV). Headquartered . . .
Kirkland & Ellis is advising CD&R on the M&A and reinvestment aspects as it enters into exclusive negotiations with Sanofi to acquire a 50% controlling stake in consumer healthcare champion, Opella, with Sanofi remaining a significant shareholder.
CD&R's acquisition of a controlling stake values Opella at approximately Euros16 billion (EV). Headquartered . . .